Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
PDS with Ranibizumab vs. Intravitreal Ranibizumab for Diabetic Macular Edema
Recruiting2 awardsPhase 3
Waterford, Connecticut
This trial will compare the effects of two different ways of delivering a drug to treat diabetic macular edema. One group will receive the drug every four weeks, and the other group will receive the drug every 24 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.